author-photo

Deyuan Jiang

22

Papers

2533

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years.

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection

2019 Journal of Medical Virology
Show All
- Source
- Cite
- Save
Citations (6)
Sofosbuvir plus ribavirin with or without peginterferon for the treatment of hepatitis C virus: Results from a phase 3b study in China: Sofosbuvir for Hepatitis C in China

2018 Journal of Gastroenterology and Hepatology
Show All
- Source
- Cite
- Save
Citations (13)
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV

2017 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (74)
Sofosbuvir plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India

2017 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (13)
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study

2016 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (77)
Ledipasvir Plus Sofosbuvir for 12 Weeks in Patients With Hepatitis C Genotype 4 Infection

2016 Hepatology
Show All
- Source
- Cite
- Save
Citations (91)
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (127)
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (105)
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

2015 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (233)